Acceleron Pharma Inc.
Methods for treating ulcers in a hemoglobinopathy anemia with a soluble actRIIB polypeptide

Last updated:

Abstract:

The present disclosure provides compositions and methods for treating or preventing ulcers in subjects having low red blood cell levels and/or hemoglobin levels (e.g, anemia). In some embodiments, the compositions of the disclosure may be used to treat or prevent ulcers associated with anemia.

Status:
Grant
Type:

Utility

Filling date:

21 Nov 2017

Issue date:

26 Nov 2019